- Home
- KPLT vs ABVC Comparison
KPLT vs ABVC Comparison
Compare KPLT & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPLT | ABVC |
|---|---|---|
| Founded | 2012 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.2M | 34.6M |
| IPO Year | 2019 | 2009 |
Fundamental Metrics
Financial Performance| Metric | KPLT | ABVC |
|---|---|---|
| Price | $9.46 | $1.15 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 129.4K | 114.4K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 98.15 | 7.14 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $291,761,000.00 | $509,589.00 |
| Revenue This Year | $18.62 | N/A |
| Revenue Next Year | $15.34 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 18.03 | N/A |
| 52 Week Low | $5.30 | $0.71 |
| 52 Week High | $19.68 | $3.39 |
Technical Indicators
Market Signals| Indicator | KPLT | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 68.95 | 62.46 |
| Support Level | $6.05 | $0.96 |
| Resistance Level | $9.21 | $1.47 |
| Average True Range (ATR) | 0.74 | 0.09 |
| MACD | 0.21 | 0.04 |
| Stochastic Oscillator | 90.21 | 82.05 |
Price Performance
Historical ComparisonAbout KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.